Cutaneous Neurodiagnostics (CND) Life Sciences is a leading diagnostic company based in Phoenix, AZ. They specialize in providing accurate and convenient diagnostic tools for the diagnosis of synucleinopathies, including Parkinson's disease and related disorders. Their Syn-One Test, the first commercially available skin-based test, offers high accuracy with a sensitivity and specificity of 95%. CND is dedicated to science, research, quality, and reliability, and their mission is to provide reliable diagnostic technologies and useful insights to optimize patient care.
CND Life Sciences is committed to empowering patients and caregivers by providing physicians with objective pathological insights through their suite of neurodiagnostic tests. With their CLIA-certified and CAP-accredited pathology lab, clinicians can easily request a Skin Biopsy Test Kit to collect skin biopsies for analysis. CND's commitment to advancing the field of neurodiagnostics is evident through their dedication to research, clinical trials, and scientific affairs, as well as their collaboration with biopharma clients. With their expertise and innovative approach, CND Life Sciences is revolutionizing the diagnosis and understanding of neurodegenerative diseases.
Generated from the website